Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force
Tina Parciak(Universitätsmedizin Göttingen), Liesbet M. Peeters(Hasselt University), Meritxell Sabidó(Merck KGaA, Darmstadt (Germany)), Magd Zakaria(Ain Shams University), Lotte Geys(Hasselt University), Elena H. Martínez‐Lapiscina(Hospital Clínic de Barcelona), Francis Arickx(Rijksinstituut voor Ziekte- en Invaliditeitsverzekering), Anne Helme(Multiple Sclerosis International Federation), Amber Salter(Salter School), Maria Pamela Dobay(Biogen (Switzerland)), Anneke van der Walt(The Alfred Hospital), Juan Ignacio Rojas(Hospital Universitario Austral), Gıancarlo Comı(Vita-Salute San Raffaele University), Alexander Stahmann(Unknown), Pietro Iaffaldano(University of Bari Aldo Moro), Jan Hillert, Kelly Plueschke(European Medicines Agency), Ingrid van der Mei(University of Tasmania), Rod Middleton(Swansea University), Hollie Schmidt(Research Network (United States)), Melinda Magyari(University of Copenhagen)
Cited by 12
Related Papers
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Multiple Sclerosis Severity Score
|Neurology|2005|957
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706